A detailed history of Lpl Financial LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 50,480 shares of ALT stock, worth $440,690. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,480
Previous 51,662 2.29%
Holding current value
$440,690
Previous $343,000 9.91%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$5.5 - $8.1 $6,501 - $9,574
-1,182 Reduced 2.29%
50,480 $309,000
Q2 2024

Aug 07, 2024

SELL
$5.91 - $10.23 $10,442 - $18,076
-1,767 Reduced 3.31%
51,662 $343,000
Q1 2024

May 10, 2024

BUY
$8.22 - $13.81 $156,073 - $262,210
18,987 Added 55.13%
53,429 $543,000
Q4 2023

Feb 14, 2024

BUY
$2.14 - $11.62 $73,705 - $400,216
34,442 New
34,442 $387,000

Others Institutions Holding ALT

About Altimmune, Inc.


  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $428M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.